Episode 10: Speculating our faces off on the current landscape of GLP1s - podcast episode cover

Episode 10: Speculating our faces off on the current landscape of GLP1s

Jun 06, 20231 hr 23 minSeason 1Ep. 10
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Resources for the Community:
___________________________________________________________________

Ro - Telehealth for GLP1 weight management 

https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55

Ro GLP-1 Insurance Checker 

https://ro.co/weight-loss/glp1-insurance-checker/

Ro GLP-1 Supply and Shortage Tracker 

https://ro.co/weight-loss/supply-tracker/

Learn more about Obesity 

https://www.obesityaction.org/
______________________________________________________________________

Our latest episode takes a slightly different format than usual. It's important to note that this episode is primarily opinion-based and should not be taken as fact. We hope you find it as entertaining as we did making it!

We're joined by Lisa, a guest from the community who works in the pharmaceutical industry. Lisa bravely shares her personal journey with lifelong weight struggles and diet culture and discusses how GLP1s have helped her manage various health conditions such as PCOS, hypothyroidism, and obesity.

Lisa then joins The Plus SideZ Crew to "speculate our faces off" on topics including:

  • The state of the original and newest Mounjaro savings card, 
  • The impending FDA approval for the obesity indication for Mounjaro, 
  • Pharmacy Benefit Managers (PBMs) leveraging our community TikToks for intel as they crackdown on the off-label use of Mounjaro, Ozempic, and other GLP-1s,
  • Pharmacy benefit managers (PBMs) conducting audits and withdrawing approved prior authorizations (PAs) for GLP-1 drugs,
  • Emerging, wild TikTok trends in June claiming "GLP-1 dupes" driven by the original Mounjaro savings card ending, and
  • The benefits and dangers of some compound pharmacies providing GLP-1s like Semaglutide during and after the listed FDA shortage. 

Follow us on TikTok:
Kim @dinosaurmonkeyfartsKim
Kat @KatCarter7
Lisa  @lisag_oc

And don't forget to subscribe and watch the show on YouTube @ThePlusSideZ 
______________________________________________________________________

⭐️Mounjaro Stanley⭐️

griffintumblerco.Etsy.com

Use code PODCAST10 for $ OFF
______________________________________________________________________

Join this channel to get access to perks:

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer

TikTok

https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc

Instagram

https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr

Kat Carter, Associate Producer

TikTok

https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc

Instagram

https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

For the best experience, listen in Metacast app for iOS or Android